Mao Geping Cosmetics (SEHK:1318) Margin Strength And 36.7% Earnings Growth Reinforce Bullish Narratives

Mao Geping Cosmetics (SEHK:1318) has just posted fresh FY 2025 numbers, with first half revenue of CNY 2,588.2 million and basic EPS of CNY 1.37. This is set against trailing twelve month revenue of CNY 5,050.5 million and EPS of CNY 2.46, alongside net earnings growth of 36.7% over the past year. Over recent periods, the company has seen revenue move from CNY 1,971.5 million in 1H 2024 to CNY 1,913.2 million in 2H 2024 and then to CNY 2,588.2 million in 1H 2025. Net income (excluding extra items) shifted from CNY 492.1 million to CNY 388.5 million and then to CNY 669.8 million. The trailing net profit margin sits at 23.8% compared with 22.7% a year earlier, which gives this result a clear profitability focus for investors.

See our full analysis for Mao Geping Cosmetics.

With the headline figures on the table, the next step is to see how this earnings profile matches up against the widely held narratives around growth, quality, and risk for Mao Geping Cosmetics.

Curious how numbers become stories that shape markets? Explore Community Narratives

36.7% earnings growth and margin strength

• Net income, on a trailing twelve month basis, is CNY 1,204.1 million with a 23.8% net margin, compared with 22.7% a year earlier and 36.7% earnings growth over that period.
• What stands out for the bullish view is how this earnings growth lines up with the current margin profile, because:
  • Trailing revenue of CNY 5,050.5 million paired with CNY 1,204.1 million of net income shows the company is converting a sizeable share of sales into profit at the 23.8% margin level.
  • Bulls also point to the 28.6% average earnings growth over five years as consistent with the latest 36.7% annual increase, which supports the idea of an established earnings track record rather than a one off spike.

Valuation gap and P/E premium tension

• The shares trade at HK$74.35, with a trailing P/E of 26.7x, compared with a peer average of 12.5x and an industry average of 21x, while the supplied DCF fair value is HK$153.64 and the single analyst target given is HK$119.46.
• For a cautious or bearish take, the key tension is between that premium P/E and the valuation models, because:
  • Critics highlight that paying 26.7x earnings when peers are at 12.5x and the wider Asian Personal Products group is at 21x means the stock is already priced above many alternatives on trailing numbers.
  • At the same time, the DCF fair value of HK$153.64 and the HK$119.46 analyst target are both above the current HK$74.35 price, which challenges a simple bearish claim that the share price is stretched relative to fundamental estimates.

On this kind of earnings print, some investors focus on whether the premium P/E is justified by the growth and DCF upside, while others question if the stock already prices in too much good news, so it is worth seeing how different valuation models line up with these results before making a call on the shares. Curious how numbers become stories that shape markets? Explore Community Narratives.

EPS swings across recent halves

• Basic EPS moved from CNY 2.46 in 1H 2024 to CNY 0.64 in 2H 2024 and then CNY 1.37 in 1H 2025, while trailing twelve month EPS sits at CNY 2.46.
• For investors taking a more bullish angle, these shifts are often weighed against the longer term pattern, because:
  • Supporters argue that, even with semi annual swings, trailing EPS of CNY 2.46 and trailing net income of CNY 1,204.1 million still line up with the 36.7% earnings growth shown for the past year.
  • They also note that forecasts in the data call for earnings growth of roughly 23% to 23.4% a year and revenue growth of about 21.9% a year, which, if met, would be consistent with the stronger periods seen in the recent EPS series.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Mao Geping Cosmetics's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

With sentiment split between attractive earnings figures and valuation questions, it helps to review the data firsthand and decide what matters most for your portfolio. To see how investors are weighing both sides of the story, check out the 4 key rewards and 1 important warning sign

See What Else Is Out There

The premium 26.7x P/E, compared with lower peer and industry averages, suggests you might be paying up here when more attractively priced ideas could exist.

If that valuation premium makes you hesitate, put it to work by scanning for other ideas using the 234 high quality undervalued stocks, so you can immediately see stocks priced more tightly against their fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com